Folate plays an important role in the production and nutritional content of breastmilk. Research has suggested that certain genetic variants involved in folate metabolism, such as MTHFR, may impact breastfeeding.
Pregnant and breastfeeding women are routinely prescribed folic acid to support the body’s folate requirements. However, common MTHFR variants such as C677T reduce MTHFR enzyme activity, which can lead to low folate levels, higher homocysteine, and higher levels of unmetabolized folic acid (UMFA) when taking folic acid supplements.1
Research has shown that taking folic acid above the recommended 400 µg/d can lead to increased levels of unmetabolized folic acid (UMFA) and reduce the proportion of active, reduced folate forms.2
The MTHFR C677T genotype is associated with lower levels of folate, higher homocysteine, and altered red blood cell folate vitamer distribution.3